BJL
EW icon

Brighton Jones LLC’s Edwards Lifesciences EW Stock Holding History

Brighton Jones LLC’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$745K Sell
8,236
-1,984
-19% -$166K 0.01% 620
2026
Q1 		$818K Buy
+10,220
New +$843K 0.02% 528
2025
Q4 		– Sell
-10,833
Closed -$842K – 342
2025
Q3 		$842K Buy
10,833
+5,648
+109% +$441K 0.02% 450
2025
Q2 		$406K Buy
5,185
+805
+18% +$60K 0.01% 603
2025
Q1 		$317K Buy
4,380
+793
+22% +$56.8K 0.01% 518
2024
Q4 		$266K Buy
+3,587
New +$251K 0.01% 555
2024
Q3 		– Sell
-3,742
Closed -$346K – 610
2024
Q2 		$346K Buy
3,742
+339
+10% +$30K 0.01% 440
2024
Q1 		$325K Buy
3,403
+222
+7% +$18.6K 0.01% 441
2023
Q4 		$243K Sell
3,181
-25
-0.8% -$1.74K 0.01% 490
2023
Q3 		$222K Sell
3,206
-184
-5% -$14.8K 0.01% 477
2023
Q2 		$320K Buy
3,390
+576
+20% +$50.1K 0.02% 382
2023
Q1 		$233K Buy
+2,814
New +$221K 0.01% 434
2022
Q4 		– Sell
-2,462
Closed -$203K – 491
2022
Q3 		$203K Buy
2,462
+74
+3% +$7.12K 0.01% 421
2022
Q2 		$227K Buy
2,388
+57
+2% +$5.9K 0.01% 396
2022
Q1 		$274K Buy
2,331
+90
+4% +$10.1K 0.01% 387
2021
Q4 		$290K Buy
2,241
+29
+1% +$3.38K 0.01% 383
2021
Q3 		$250K Buy
2,212
+62
+3% +$7.08K 0.01% 400
2021
Q2 		$223K Buy
+2,150
New +$203K 0.01% 431
2020
Q4 		– Sell
-3,039
Closed -$243K – 397
2020
Q3 		$243K Buy
3,039
+63
+2% +$4.92K 0.02% 284
2020
Q2 		$206K Sell
2,976
-282
-9% -$20K 0.02% 274
2020
Q1 		$205K Buy
3,258
+24
+0.7% +$1.73K 0.02% 256
2019
Q4 		$251K Sell
3,234
-108
-3% -$8.43K 0.03% 279
2019
Q3 		$245K Buy
+3,342
New +$235K 0.03% 256
2019
Q2 		– Sell
-3,579
Closed -$228K – 314
2019
Q1 		$228K Buy
+3,579
New +$204K 0.03% 273

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Brighton Jones LLC's EW Position: Q2 2026 in Review

Brighton Jones LLC reduced its Edwards Lifesciences (EW) stake by 19% in Q2 2026, selling an estimated $166K and leaving 8,236 shares worth $745K. The position accounts for 0.01% of the portfolio, ranked #620.

Brighton Jones LLC first reported a position in EW in Q1 2019 and has held it in 24 quarters since. The position peaked at $842K in Q3 2025. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Brighton Jones LLC held 8,236 shares of Edwards Lifesciences worth $745K as of Q2 2026.
  • Brighton Jones LLC sold 1,984 Edwards Lifesciences shares in Q2 2026, an estimated $166K.
  • Edwards Lifesciences made up 0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #620 holding.
  • Brighton Jones LLC first reported a position in Edwards Lifesciences in Q1 2019 and has held it in 24 quarters since.
  • Brighton Jones LLC's Edwards Lifesciences position peaked at $842K in Q3 2025.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.